theory clinical_106_1
imports Main

begin

typedecl entity
typedecl event

consts
  HER2V777L :: "entity ⇒ bool"
  HER2Amplification :: "entity ⇒ bool"
  BreastCancer :: "entity ⇒ bool"
  TrastuzumabResistance :: "event ⇒ bool"
  CoincidentWith :: "entity ⇒ entity ⇒ bool"
  In :: "entity ⇒ entity ⇒ bool"
  Developed :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Mechanism :: "entity ⇒ bool"
  Resistance :: "entity ⇒ bool"
  AntibodyTherapy :: "entity ⇒ bool"
  Trastuzumab :: "entity ⇒ bool"
  Contribute :: "event ⇒ bool"
  Patient :: "entity ⇒ bool"
  Lead :: "event ⇒ bool"
  TrastuzumabTherapy :: "entity ⇒ bool"
  Develop :: "event ⇒ bool"
  Cause :: "event ⇒ bool"

(* Explanation 1: HER2 V777L is coincident with HER2-amplification in breast cancers that have developed trastuzumab resistance. *)
axiomatization where
  explanation_1: "∃x y z e. HER2V777L x ∧ HER2Amplification y ∧ BreastCancer z ∧ TrastuzumabResistance e ∧ CoincidentWith x y ∧ In y z ∧ Developed e ∧ Agent e z"

(* Explanation 2: HER2 V777L may contribute to mechanisms that lead to resistance to antibody therapies, including Trastuzumab. *)
axiomatization where
  explanation_2: "∃x y z e1 e2. HER2V777L x ∧ Mechanism y ∧ Resistance z ∧ AntibodyTherapy z ∧ Trastuzumab z ∧ Contribute e1 ∧ Agent e1 x ∧ Agent e1 y ∧ Lead e2 ∧ Agent e2 y ∧ Agent e2 z"

(* Explanation 3: This patient may develop resistance to Trastuzumab therapy. *)
axiomatization where
  explanation_3: "∃x y e. Patient x ∧ Resistance y ∧ TrastuzumabTherapy y ∧ Develop e ∧ Agent e x ∧ Agent e y"

theorem hypothesis:
  assumes asm: "HER2V777L x ∧ Resistance y ∧ AntibodyTherapy y"
  (* Hypothesis: HER2 V777L may cause resistance to antibody therapy. *)
  shows "∃x y e. HER2V777L x ∧ Resistance y ∧ AntibodyTherapy y ∧ Cause e ∧ Agent e x ∧ Agent e y"
proof -
  (* From the premise, we have known information about HER2V777L, Resistance, and AntibodyTherapy. *)
  from asm have "HER2V777L x ∧ Resistance y ∧ AntibodyTherapy y" by auto
  (* Explanation 2 provides a logical relation Implies(C, D), which implies HER2 V777L contributes to mechanisms leading to resistance to antibody therapies. *)
  (* We can use this to infer that HER2 V777L may cause resistance to antibody therapy. *)
  then have "∃e. Cause e ∧ Agent e x ∧ Agent e y" sledgehammer
  then show ?thesis <ATP>
qed

end
